JWH 213 |
| Catalog No.GC41057 |
JWH 213 is a naphthoylindole-class synthetic cannabinoid (CB) which strongly binds both the central CB1 and peripheral CB2 receptor (Ki = 1.5 and 0.42 nM, respectively).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 824959-83-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
JWH 213 is a naphthoylindole-class synthetic cannabinoid (CB) which strongly binds both the central CB1 and peripheral CB2 receptor (Ki = 1.5 and 0.42 nM, respectively). [1] The physiological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications.
Reference:
[1]. Huffman, J.W., Zengin, G., Wu, M.J., et al. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: Steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg. Med. Chem. 13, 89-112 (2005).
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *